002007 Stock Overview
A biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Hualan Biological Engineering Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.94 |
| 52 Week High | CN¥24.55 |
| 52 Week Low | CN¥14.46 |
| Beta | 0.27 |
| 11 Month Change | -7.26% |
| 3 Month Change | -16.02% |
| 1 Year Change | -28.82% |
| 33 Year Change | -49.18% |
| 5 Year Change | -41.25% |
| Change since IPO | 1,348.04% |
Recent News & Updates
Why Investors Shouldn't Be Surprised By Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E
Aug 22
Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jun 26Hualan Biological Engineering's (SZSE:002007) Dividend Will Be CN¥0.30
Jun 09Recent updates
Why Investors Shouldn't Be Surprised By Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E
Aug 22Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jun 26Hualan Biological Engineering's (SZSE:002007) Dividend Will Be CN¥0.30
Jun 09These 4 Measures Indicate That Hualan Biological Engineering (SZSE:002007) Is Using Debt Safely
Jun 07Lacklustre Performance Is Driving Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E
May 21Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?
Feb 27Shareholder Returns
| 002007 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -0.9% | -3.1% | -2.4% |
| 1Y | -28.8% | -23.9% | -20.1% |
Return vs Industry: 002007 underperformed the CN Biotechs industry which returned -22.3% over the past year.
Return vs Market: 002007 underperformed the CN Market which returned -19.1% over the past year.
Price Volatility
| 002007 volatility | |
|---|---|
| 002007 Average Weekly Movement | 3.9% |
| Biotechs Industry Average Movement | 5.9% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 8.7% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 002007's share price has been volatile over the past 3 months.
Volatility Over Time: 002007's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 3,709 | Bei Fan | www.hualanbio.com |
Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People’s Republic of China. Its blood products comprise human albumin, human immunoglobulin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, human prothrombin complex, human coagulation factor VIII, lyophilized human thrombin for external use, freeze-dried human fibrin glue for surgery, and human fibrinogen. The company’s vaccines consist of influenza virus split vaccine, recombinant hepatitis B vaccine, ACYW135 meningococcal polysaccharide vaccine, A H1N1 influenza virus split vaccine, and quadrivalent influenza virus split vaccine.
Hualan Biological Engineering Inc. Fundamentals Summary
| 002007 fundamental statistics | |
|---|---|
| Market cap | CN¥27.32b |
| Earnings (TTM) | CN¥1.40b |
| Revenue (TTM) | CN¥5.41b |
19.6x
P/E Ratio5.1x
P/S RatioIs 002007 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002007 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.41b |
| Cost of Revenue | CN¥1.91b |
| Gross Profit | CN¥3.50b |
| Other Expenses | CN¥2.11b |
| Earnings | CN¥1.40b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.76 |
| Gross Margin | 64.77% |
| Net Profit Margin | 25.79% |
| Debt/Equity Ratio | 8.0% |
How did 002007 perform over the long term?
See historical performance and comparison